Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Oceane Duboust

Meet Aqemia, the French start-up leveraging AI-backed physics tools for drug discovery

A startup in France is leveraging artificial intelligence-backed physics principles in the hope of speeding up the process of making new drugs.

Currently, developing a new medicine takes a company 10 to 15 years on average, with research conducted in a lab environment – and a lot of trial and error before they enter multiple stages of human clinical trials.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.